Markets extended their morning gains during afternoon trading on Thursday, with the Sensex climbing 665.50 points or 0.82 per cent to 81,663.75 and the Nifty advancing 208.10 points or 0.85 per cent to 24,828.30. The benchmark indices maintained their upward momentum from the opening session, where the Sensex had started at 81,196.08 and the Nifty at 24,691.20.
Pharmaceutical and retail stocks continued to lead the market advance, with Dr Reddy’s Laboratories emerging as the top Nifty gainer, surging 3.44 per cent to 1,295.00. Trent followed closely with a 3.15 per cent gain to 5,680.00, while Eternal Ltd posted the highest gain of 5.43 per cent to 259.02. Power Grid Corporation added 2.24 per cent to 295.00, and Shriram Finance rose 1.89 per cent to 653.35.
Financial stocks showed a mixed performance, with IndusInd Bank leading the decliners with a 1.15 per cent drop to 805.00. Bajaj Finance fell 0.45 per cent to 8,947.00, continuing its morning weakness. Maruti Suzuki declined 0.31 per cent to 12,125.00, while Tata Consumer Products and Asian Paints registered marginal losses of 0.18 per cent and 0.13 per cent, respectively.
The market breadth remained positive across the BSE, with 2,456 stocks advancing, against 1,333 declining issues. A total of 3,976 stocks were actively traded, while 187 remained unchanged. The session witnessed 97 stocks hitting 52-week highs, compared to 26 touching 52-week lows. Circuit activity showed 234 stocks in the upper circuit and 179 in the lower circuit.
Sectoral indices displayed broad-based gains, with the Nifty Next 50 rising 0.73 per cent to 67,351.85 and the Nifty Midcap 100 advancing 0.73 per cent to 58,346.70. The Nifty Financial Services index gained 0.61 per cent to 26,425.15, while the Bank Nifty posted a modest 0.30 per cent increase to 55,842.00.
The sustained buying interest reflects continued optimism despite global uncertainties, with investors maintaining their focus on domestic fundamentals. Foreign institutional investors’ return to net buying territory and domestic institutional investors extended their purchasing streak, providing additional support to market sentiment.
Trading volumes remained healthy across segments, with significant activity in the pharmaceutical and retail counters. The market’s ability to sustain gains through the afternoon session indicates underlying strength, though analysts continue to monitor global developments and upcoming policy announcements for directional cues.
Published on June 5, 2025